$0.00030
At close: Apr 14, 2:48 PM EDT
Comments
Loading...
Marizyme Analyst Ratings and Price Targets | OTC:MRZM | Benzinga
Marizyme Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Marizyme Corp from these most-recent analyst ratings.
Analyst Ratings for Marizyme
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Marizyme (MRZM) stock?
There is no price target for Marizyme
What is the most recent analyst rating for Marizyme (MRZM)?
There is no analyst for Marizyme
When was the last upgrade for Marizyme (MRZM)?
There is no last upgrade for Marizyme
When was the last downgrade for Marizyme (MRZM)?
There is no last downgrade for Marizyme.
When is the next analyst rating going to be posted or updated for Marizyme (MRZM)?
There is no next analyst rating for Marizyme.
Is the Analyst Rating Marizyme (MRZM) correct?
There is no next analyst rating for Marizyme.
Browse analyst ratings and price targets on all stocks.
